These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26589913)

  • 1. PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function.
    Sato K; Feng X; Chen J; Li J; Muranski P; Desierto MJ; Keyvanfar K; Malide D; Kajigaya S; Young NS
    Haematologica; 2016 Jan; 101(1):57-67. PubMed ID: 26589913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of PPARγ increases osteoblastogenesis and bone mass in male C57BL/6 mice.
    Duque G; Li W; Vidal C; Bermeo S; Rivas D; Henderson J
    J Bone Miner Res; 2013 Mar; 28(3):639-48. PubMed ID: 23044841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis.
    Zhu RJ; Wu MQ; Li ZJ; Zhang Y; Liu KY
    Int J Hematol; 2013 Jan; 97(1):58-72. PubMed ID: 23264188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PPARγ by bisphenol A diglycidyl ether ameliorates dexamethasone-induced osteoporosis in a mouse model.
    Wang Y; Pan Z; Chen F
    J Int Med Res; 2019 Dec; 47(12):6268-6277. PubMed ID: 31709877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Botolin S; McCabe LR
    J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of bisphenol A diglicydyl ether on bone quality and marrow adiposity in ovary-intact and ovariectomized rats.
    Li G; Xu Z; Hou L; Li X; Li X; Yuan W; Polat M; Chang S
    Am J Physiol Endocrinol Metab; 2016 Dec; 311(6):E922-E927. PubMed ID: 27756728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
    Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
    Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.
    Naveiras O; Nardi V; Wenzel PL; Hauschka PV; Fahey F; Daley GQ
    Nature; 2009 Jul; 460(7252):259-63. PubMed ID: 19516257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can bisphenol A diglycidyl ether (BADGE) administration prevent steroid-induced femoral head osteonecrosis in the early stage?
    Aimaiti A; Wufuer M; Wang YH; Saiyiti M; Cui L; Yusufu A
    Med Hypotheses; 2011 Aug; 77(2):282-5. PubMed ID: 21620573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
    Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
    J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model.
    Yuan N; Li J; Li M; Ji W; Ge Z; Fan L; Wang K
    BMC Musculoskelet Disord; 2018 Apr; 19(1):129. PubMed ID: 29703208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARγ mRNA, in 3T3-L1 adipocytes.
    Oster RT; Tishinsky JM; Yuan Z; Robinson LE
    Appl Physiol Nutr Metab; 2010 Dec; 35(6):783-9. PubMed ID: 21164549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of PPARγ inhibitor on bones and bone marrow fat in aged glucocorticoid-treated female rats.
    Fan J; Zhang D; Jiang Y; Yu L; Han B; Qian Z
    Exp Gerontol; 2023 Oct; 181():112281. PubMed ID: 37659742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway.
    Mo C; Chearwae W; Bright JJ
    Cell Signal; 2010 Mar; 22(3):495-500. PubMed ID: 19922793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explicit role of peroxisome proliferator-activated receptor gamma in gallic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury in rats.
    Singh JP; Singh AP; Bhatti R
    J Surg Res; 2014 Apr; 187(2):631-9. PubMed ID: 24433871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
    Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
    Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
    Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.